Covered recipient · General Payments record
KELVIN ONG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$779.53
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.05 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $57.52 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $31.64 | 2 |
| PFIZER INC. | $26.39 | 1 |
| Acerta Pharma LLC | $24.04 | 1 |
| DEXCOM, INC. | $23.12 | 1 |
| Exeltis, USA Inc. | $19.73 | 1 |
| Exact Sciences Corporation | $18.88 | 1 |
| Novo Nordisk AS | $16.16 | 1 |
| Amgen Inc. | $14.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.28 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105155249 | CMS |
| ABBVIE INC. | $17.89 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105155251 | CMS |
| ABBVIE INC. | $18.35 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105155253 | CMS |
| Amgen Inc. | $14.57 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117343570 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.04 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105775482 | CMS |
| Dexcom, Inc. | $23.12 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153313802 | CMS |
| Exact Sciences Corporation | $18.88 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114816965 | CMS |
| Exeltis, USA Inc. | $19.73 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150001118 | CMS |
| Novartis Pharmaceuticals Corporation | $17.89 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087191881 | CMS |
| Novartis Pharmaceuticals Corporation | $13.75 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087191887 | CMS |
| Novo Nordisk Inc | $16.16 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096869274 | CMS |
| PFIZER INC. | $26.39 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130940755 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.